Patent · US Active

Compounds for the treatment of neuromuscular disorders

US11147788B2 · kind B2 · utility

1Cited by
9References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2017
Grant dateOct 19, 2021
Priority date
Expiry dateDec 14, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein preferably inhibit the CIC-1 ion channel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.